Founders Capital Management Zynerba Pharmaceuticals, Inc. Transaction History

Founders Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 09, 2023	SELL	$0.5 - $0.72 $500 - $720	-1,000 Reduced 33.33%	2,000 $1,000
Q3 2021 Oct 12, 2021	BUY	$3.72 - $5.35 $3,720 - $5,350	1,000 Added 50.0%	3,000 $13,000
Q1 2020 Apr 22, 2020	BUY	$2.9 - $6.16 $2,900 - $6,160	1,000 Added 100.0%	2,000 $18,000
Q3 2018 Oct 05, 2018	BUY	$5.59 - $10.45 $5,590 - $10,450	1,000 New	1,000 $8,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Founders Capital Management, based on Form 13F filings with the SEC.

Stay updated on Founders Capital Management with notifications on news.